Home | Careers | Contact Us | Location Map | Sign In

Product Portfolio New Launches Special Programmes Essential Updates Your Health Publications     ---Product Search--- Pain Management Vaccines Diabetes Management Anti Osteoporotic Anti - Pyretic , Analgesic Renal Disease Management Gastro Intestinal Constipation Anti Tubercular Cough Cold   Home >> Medical Zone > Essential Updates EMEA recommends restricted use of nimesulide-containing medicinal products Dated : 21 September 2007 European Medicines Agency review concludes positive benefit-risk balance for non-selective NSAIDs Dated : 24 October 2006 European Medicines Agency update on review of non-selective NSAIDs Dated : 26 September 2006 Questions and Answers on the Review of Non-Selective NSAIDs -EMEA Dated : 24 October 2006 Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) Dated : 07 May 2004 European Medicines Agency concludes action on COX-2 inhibitors Dated : 27 June 2005 Cardiovascular safety of  non-selective NSAIDs Dated : 02 August 2005 No new safety concerns regarding cardiovascular and gastrointestinal safety and serious skin reactions with non-selective NSAIDs Dated : 17 October 2005 EMEA Public statement on the suspension of the Marketing Authorization for BEXTRA (valdecoxib) In the European Union Dated : 27 October 2005 Guideline on the Non-Clinical Documentation for  Mixed Marketing Authorization Applications Dated : 13 October 2005

Home | Contact Us | Sitemap | Disclaimer | Privacy Policy Copyright © 2007 Panacea Biotec. All Rights Reserved.